Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry

Abstract

BackgroundParadoxically, beneficial effects of overweight and obesity on survival have been found in patients after cardiovascular events such as acute myocardial infarction (AMI). This obesity paradox has not been analyzed in AMI patients with diabetes even though their cardiovascular morbidity and mortality is increased compared to their counterparts without diabetes. Therefore, the objective of this long-term study was to analyze the association between body mass index (BMI) and all-cause mortality in AMI patients with and without diabetes mellitus.MethodsIncluded in the study were 1190 patients with and 2864 patients without diabetes, aged 28-74 years, recruited from a German population-based AMI registry. Patients were consecutively hospitalized between 1 January 2000 and 31 December 2008 with a first ever AMI and followed up until December 2011. Data collection comprised standardized interviews and chart reviews. To assess the association between BMI and long-term mortality from all causes, Cox proportional hazards models were calculated adjusted for risk factors, co-morbidities, clinical characteristics, in-hospital complications as well as medical and drug treatment.ResultsAMI patients of normal weight (BMI 18.5-24.9 kg/m2) had the highest long-term mortality rate both in patients with and without diabetes with 50 deaths per 1000 person years and 26 deaths per 1000 person years, respectively. After adjusting for a selection of covariates, a significant, protective effect of overweight and obesity on all-cause mortality was found in AMI patients without diabetes (overweight: hazard ratio (HR) 0.73, 95% confidence interval (CI) 0.58-0.93; p=0.009; obesity: HR 0.64, 95% CI 0.47-0.87; p=0.004). In contrast, an obesity paradox was not found in AMI patients with diabetes. However, stratified analyses showed survival benefits in overweight AMI patients with diabetes who had been prescribed statins prior to AMI (HR 0.51, 95% CI 0.29-0.89, p=0.018) or four evidence-based medications at hospital-discharge (HR 0.52, 95% CI 0.34-0.80, p=0.003).ConclusionIn contrast to AMI patients without diabetes, AMI patients with diabetes do not experience a survival benefit from an elevated BMI. To investigate the underlying reasons for these findings, further studies stratifying their samples by diabetes status are needed.Electronic supplementary materialThe online version of this article (doi:10.1186/s12933-015-0189-0) contains supplementary material, which is available to authorized users.

Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism

“…In prospective clinical studies, overweight or obese individuals have increased rates of cardiovascular diseases [1, 3, 41], contributing to a 2–3 fold increase in overall mortality relative to normal weight individuals[1, 7, 15, 32, 49, 51]. In addition to a direct link with occlusive vascular disease, obesity is strongly associated with impairment of systolic and diastolic function and the development of cardiac fibrosis (i.e.…”

Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetic status: Korean cohort study

“…The MONICA/KORA study with 4,504 patients after MI demonstrated the relationship between obesity and CV outcomes regarding the presence of diabetes during 6 years. Higher BMI decreased the risk of long-term survival in patients without diabetes, although diabetes attenuated the protective role of obesity [23].…”

Four varieties of diabetes mellitus in acute myocardial infarction

“…DM confers increased in-hospital mortality risk both in the ST-elevation myocardial infarction (STEMI) and the non-STEMI (NSTEMI) patients 19 . Moreover, this dismal prognosis of patients with AMI and DM is not related to the body mass index, i.e., "obesity paradox" is not relevant to them (in contrast to the AMI patients without DM) 20 . Indeed, a meta-analysis of 21,759 DM patients (~29% of them were insulin-treated) revealed that both short-term and long-term mortality, and the incidence of new AMI, target lesion revascularization, major adverse cardiac effect (MACE), and stent thrombosis were significantly more frequent in the insulin-treated DM patients 21 .…”